Information on nosocomial infections in the mainstream media: an opinion document.

This paper seeks to explore the reasons for the low impact of nosocomial infection in the mainstream media and the responsibilities of physicians and journalists in terms of this situation. To this end, a small group of 13 experts met for round-table discussions, including physicians with expertise in nosocomial infection, medical lawsuits and ethics, as well as journalists from major mainstream Spanish media outlets. The various participants were asked a series of questions prior to the meeting, which were answered in writing by one of the speakers and discussed during the meeting by the whole group, the aim being to obtain consensual conclusions for each of them. The document was subsequently reviewed, edited and forwarded to all co-authors for their agreement. The opinions expressed are the personal opinions of the participants and not necessarily those of the institutions in which they work or with which they collaborate.

Hyperkalemic cardiac arrest, prolonged heart massage and simultaneous hemodialysis.

A 53 year old diabetic patient underwent CABG and aortic valve replacement in another institution and developed postoperative oliguric and hyperkalemic acute renal failure. Shortly after transferring to our unit a cardiac arrest occurred. Immediate resuscitative measures were ineffective. The serum potassium level was 10.2 mmol/l. Conventional arteriovenous hemodialysis was initiated while the patient was still undergoing cardiac massage. When the serum potassium level was lowered to 6.5 mmol/l, 90 min later, the heart began to beat. After hemodialysis was discontinued the patient was reactive and fully conscious. The use of simultaneous hemodialysis with prolonged mechanical heart massage as a reliable method for recovery in hyperkalemic cardiac standstill is stressed.

Association of a low serum albumin with infection and increased mortality in critically ill patients.

214 patients among 282 consecutive admissions had at least one measurement of serum albumin (SA) during their stay on the ICU and were classified according to their lowest value of SA. Mean SA was 2.88 /+- 0.74 g/100 mg. Survivors had a mean SA (3.18 /+- 0.60) higher than non-survivors (2.35 /+- 0.68 g/100 ml) (p < 0.05). 64% of patients were admitted with an abnormally low SA (less than 3.5 g/100 ml) and in 56% of these the initial value was higher than the last. Mortality increased in the groups with lower SA and the level of SA was associated with infection (x2 = 73.9) and mortality (x2 = 69.7) (p < 0.05). The percentage of infected patients who died increased in groups with lower SA.

Fibrinogen/fibrin degradation products in the diagnosis of pulmonary embolism in critically ill patients.

The concentration of fibrinogen/fibrin degradation products (FDP/fdp) was measured using a direct latex agglutination tests in 40 critically ill patients with pulmonary arteriography and possible acute pulmonary embolism. All of them were admitted with signs of severe heart and/or respiratory insufficiency, and 12 (30%) of the patients required mechanical ventilation. The concentration of FDP/fdp was significantly higher in 28 of 29 patients with positive arteriography (mean 145 microgram/ml), that in those whose arteriography was negative (in every cases the FDP/fdp level was lower than 10 microgram/ml). To help differentiate pulmonary embolism from other acute heart or pulmonary diseases, the authors measured the FDP/fdp in 10 patients with bacterial pneumonia, 24 patients with acute myocardial infarction, 4 patients with extrinsic asthma, and 18 normal control subjects. The authors found high levels of FDP/fdp (more than 10 microgram/ml) in only 2 patients with pneumonia and in 6 with myocardial infarction. In no case was the level of FDP/fdp higher than 40 microgram/ml. On the other hand, in patients with pulmonary embolism, 23 (79%) had levels higher than 40 microgram/ml. The study indicates that this test is a helpful screening method for pulmonary embolism, especially in situations where other emergency diagnosis tests are inconclusive or impractical; it also provides justification for beginning anticoagulant therapy and for recommending pulmonary arteriography.

Amikacin treatment of Serratia septicemia in critically ill patients.

Serratia marcescens septicemia represents a serious problem in high risk critical care patients. Treatment is difficult because Serratia is usually resistant to most antibiotics. Amikacin is at present the most effective antibiotic in vitro against gentamycin-resistant Serratia, although significant loss of activity may occur in vivo in the group of compromised patients, whose ultimate prognosis may depend eventually upon other associated conditions. In this Medical ICU, 15 patients with Serratia septicemia who were treated with in vitro effective antibiotics (14 were given amikacin) had a mortality of 60%, while 5 patients who received ineffective in vitro antibiotics had a mortality of 100%. In this ICU, 80% of the Serratia isolates were resistant to gentamycin, while only 2.8% were resistant to amikacin. Because amikacin-resistant strains of Serratia have already emerged, appropriate use of this antibiotic is essential in order not to promote the selection of amikacin-resistant strains.